EICHOR
● Active Not Recruiting
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function
Condition: Left Ventricular Dysfunction · Coronary Artery Disease · Sponsor: Abiomed Inc.
About this study
The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart procedure compared to the current standard of care.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (110)
| University of Alabama | Birmingham, Alabama, United States | — |
| St. Joseph's Medical Center - Phoenix | Phoenix, Arizona, United States | — |
| Northwest Medical Center Tucson | Tucson, Arizona, United States | — |
| Arkansas Cardiology | Little Rock, Arkansas, United States | — |
| Adventist Health Glendale | Glendale, California, United States | — |
| St. Joseph Hospital - Orange | Orange, California, United States | — |
| Loma Linda University Health | San Bernardino, California, United States | — |
| UCSD Medical Center | San Diego, California, United States | — |
| Colorado Heart and Vascular | Lakewood, Colorado, United States | — |
| Hartford Hospital | Hartford, Connecticut, United States | — |
| MedStar Washington Hospital Center | Washington D.C., District of Columbia, United States | — |
| The Cardiac & Vascular Institute | Gainesville, Florida, United States | — |
+ 98 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.